DCTs Deliver Big ROI
New study proves that choosing decentralized clinical trials enables reduced time and cost, delivering measurable benefits for sponsors.
Jul 28, 2022

In this white paper, Bhausaheb Patil, Head of Business Operations, Decentralized Clinical Trials at IQVIA shares recently completed analysis comparing the tech-enabled model to traditional study models and how DCTs delivered time and cost efficiencies at virtually every point in the clinical research journey.

Read what 14 value measures analysts used to showcase the positive trends and impacts seen by using a combination of DCT technologies and in-home support to streamline trial operations.

Related solutions

Contact Us